1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"GBA1 Parkinson's Disease Research Catalyst Program" is currently closed and not accepting applications.
GBA1 Parkinson's Disease Research Catalyst Program is sponsored by The Michael J. Fox Foundation for Parkinson's Research (in partnership with Aligning Science Across Parkinson's - ASAP). This program seeks to build a deeper, globally integrated understanding of GBA1-associated Parkinson's disease by aligning efforts across geographies and maximizing the value of shared datasets and research assets.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Dismiss Planning Ahead Together: Legal, Financial and Long-Term Care Conversations for Parkinson's: A virtual talk on August 5. _Register Now.
_ * Key Research Initiatives * Understanding Parkinson's Understanding Parkinson's * Medications & Treatments * Newly Diagnosed Resources * Mental & Physical Health * Parkinson’s IQ + You Events * Real Talk from Patients * Parkinson's Buddy Network * Open Science & Research Integrity * MJFF Scientific Publications * Collaborative Research Opportunities Key Initiatives and Findings * Find an Event/Fundraiser * Marathons, Climbs, Endurance * Team Fox Do-It-Yourself * Real Talk from Participants * Contact Your Policymakers * Our Public Policy Priorities * Parkinson's Policy News * The National Parkinson’s Project [](https://www.
michaeljfox. org/grant/gba1-parkinsons-disease-research-catalyst-program) Search for topics, articles, videos, research, etc... Hit enter to search or ESC to close [](https://www.
michaeljfox. org/grant/gba1-parkinsons-disease-research-catalyst-program) GBA1 Parkinson's Disease Research Catalyst Program # GBA1 Parkinson's Disease Research Catalyst Program The GBA1-PD Research Catalyst Program seeks to build a deeper, globally integrated understanding of GBA1-associated Parkinson’s disease by aligning efforts across geographies and maximizing the value of shared datasets and research assets.
Funding will support hypothesis-driven projects with an emphasis on integrative, cross-cohort analyses and the systematic characterization and standardization of models to enable broad use by the research community. The Michael J.
Fox Foundation (MJFF), Aligning Science Across Parkinson’s Initiative (ASAP), Parkinson’s UK, Parkinson Canada and McGill University, through the G-Can initiative, funded by The Hilary and Galen Weston Foundation, are joining forces to **advance the biological understanding of GBA1-associated Parkinson’s disease (GBA1-PD)**.
**The GBA1-PD Research Catalyst Program supports:** * Hypothesis-driven studies that define the molecular mechanisms linking GBA1 dysfunction to neurodegeneration, including interrogation of lysosomal biology, lipid metabolism, and alpha-synuclein dynamics, as well as investigations into variant-specific effects and the biological basis for disease specificity in Parkinson’s disease versus Gaucher disease.
* Research aimed at identifying modifiers of penetrance, progression, and clinical heterogeneity in GBA1-PD, leveraging existing longitudinal cohorts, multi-modal datasets, and cross-cohort analyses to uncover genetic, molecular, and environmental drivers of disease variability.
* Studies that characterize cell-type–specific and systems-level effects of GBA1 dysfunction, including work in neurons, glia, and peripheral systems, alongside efforts to rigorously evaluate, benchmark, and standardize preclinical models to improve translational relevance and reproducibility.
The funders **will prioritize** proposals that: * Integrate data across cohorts, modalities, and/or model systems to generate robust, generalizable insights into GBA1-PD biology * Leverage and enhance existing resources (e.g., cohorts, datasets, models), with clear plans for validation, standardization, and data sharing to maximize impact across the research community For this round, **we will not consider** proposals focused on the following: * Development or preclinical testing of therapeutic interventions targeting GBA1 * Studies that do not leverage existing datasets, cohorts, or preclinical model Please note that MJFF has an **Open Science Policy** which governs research outputs (such as preprints, journal articles, data, code, and software) resulting from MJFF-funded work.
The Open Science Policy applies to this funding program and includes specific rules, timing, and format for the return of those research outputs and requires them to be shared openly, to be free to access, and with persistent identifiers. Please contact **openscience@michaeljfox. org** for questions about the Open Science Policy.
1. Download the RFA overview and full proposal template. 3.
Submit your complete application. **Full Proposals Due:**July 22, 2026, 5 p. m.
US ET **Anticipated Award Announcement:** Week of October 28, 2026 _Applicants are encouraged to apply early to allow adequate time to correct errors found during the submission process. _ **Duration:**12 to 24 months **Award Amount:**Up to $300,000. Requested support should be commensurate with work proposed.
Get the latest news and resources directly to your inbox. ## Footer utility navigation ## Footer legal navigation * State Nonprofit Disclosures Here. Until Parkinson's isn't.
Help us speed a cure for the 6 million people worldwide living with Parkinson's. Join our email list to get the latest news and resources directly to your inbox.
First Name Last Name Email Zip Code Connection to Parkinson's * Immediate family member has PD * Immediate family member had PD * Extended family member or friend has PD * Extended family member or friend had PD * I am a researcher, clinician or work with the PD community What Year Were You Diagnosed with PD?
According to the current listing, eligibility includes: Researchers globally (implied by 'globally integrated understanding' and 'aligning efforts across geographies'). Confirm the full requirements in the official notice before applying.
The published deadline was July 22, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
GBA1 Parkinson's Disease Research Catalyst Program is funded by The Michael J. Fox Foundation for Parkinson's Research (in partnership with Aligning Science Across Parkinson's - ASAP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
A new Partnership for Public Service report documents 118,000 science-related federal departures between September 2024 and February 2026 — Forest Service and NSF down a third, SAMHSA down 42 percent. Project grant obligations from science agencies dropped 24 percent from 2024 to 2025. On June 3, Johns Hopkins announced a $60M annual Research Resilience Fund. Here is what the data and the institutional response mean for grant applicants.
Read articleThe Department of Energy Office of Science FY2026 solicitation covers everything from fusion energy to biological research. A strategic guide to the largest open-ended federal science funding opportunity of the year.
Read articleOn July 22, 2026, the Department of Energy opened the first Phase I SBIR/STTR release tied to its Genesis Mission — roughly 40 awards across biotechnology, AI-for-quantum, predictable-materials design, and autonomous laboratories — alongside about $147M in FY25 Phase II funding. Here is what each topic area actually wants, who is eligible, how this connects to the $5B Genesis Mission, and how a small business should position before the broader fall solicitation.
Read article